BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26170217)

  • 21. Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies.
    Sharma R; Huang X; Brekken RA; Schroit AJ
    Br J Cancer; 2017 Aug; 117(4):545-552. PubMed ID: 28641308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early detection of pancreatic cancer: Where are we now and where are we going?
    Zhou B; Xu JW; Cheng YG; Gao JY; Hu SY; Wang L; Zhan HX
    Int J Cancer; 2017 Jul; 141(2):231-241. PubMed ID: 28240774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosome Migration Inhibitory Factor as a Marker and Therapeutic Target for Pancreatic Cancer.
    Matsushita H; Yang YM; Pandol SJ; Seki E
    Gastroenterology; 2016 Apr; 150(4):1033-5. PubMed ID: 26922869
    [No Abstract]   [Full Text] [Related]  

  • 24. Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function.
    Osterman CJ; Lynch JC; Leaf P; Gonda A; Ferguson Bennit HR; Griffiths D; Wall NR
    PLoS One; 2015; 10(7):e0132845. PubMed ID: 26177391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
    Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
    World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer.
    Guo J; Xie K; Zheng S
    Int J Biol Sci; 2016; 12(3):292-301. PubMed ID: 26929736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic cancer-associated diabetes is an "exosomopathy".
    Korc M
    Clin Cancer Res; 2015 Apr; 21(7):1508-10. PubMed ID: 25645860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Label-Free Nanoplasmonic-Based Short Noncoding RNA Sensing at Attomolar Concentrations Allows for Quantitative and Highly Specific Assay of MicroRNA-10b in Biological Fluids and Circulating Exosomes.
    Joshi GK; Deitz-McElyea S; Liyanage T; Lawrence K; Mali S; Sardar R; Korc M
    ACS Nano; 2015 Nov; 9(11):11075-89. PubMed ID: 26444644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomes derived from pancreatic cancer cells induce activation and profibrogenic activities in pancreatic stellate cells.
    Masamune A; Yoshida N; Hamada S; Takikawa T; Nabeshima T; Shimosegawa T
    Biochem Biophys Res Commun; 2018 Jan; 495(1):71-77. PubMed ID: 29111329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue.
    Sagar G; Sah RP; Javeed N; Dutta SK; Smyrk TC; Lau JS; Giorgadze N; Tchkonia T; Kirkland JL; Chari ST; Mukhopadhyay D
    Gut; 2016 Jul; 65(7):1165-74. PubMed ID: 26061593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of precision medicine in pancreatic cancer prevention and treatment].
    Wang CF
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):161-4. PubMed ID: 26988819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies.
    Cheng L; Wu S; Zhang K; Qing Y; Xu T
    J Ovarian Res; 2017 Nov; 10(1):73. PubMed ID: 29100532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATF1 and RAS in exosomes are potential clinical diagnostic markers for cervical cancer.
    Shi Y; Wang W; Yang B; Tian H
    Cell Biochem Funct; 2017 Oct; 35(7):477-483. PubMed ID: 29023897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis.
    Li Y; Zheng Q; Bao C; Li S; Guo W; Zhao J; Chen D; Gu J; He X; Huang S
    Cell Res; 2015 Aug; 25(8):981-4. PubMed ID: 26138677
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection and proteomic characterization of extracellular vesicles in human pancreatic juice.
    Osteikoetxea X; Benke M; Rodriguez M; Pálóczi K; Sódar BW; Szvicsek Z; Szabó-Taylor K; Vukman KV; Kittel Á; Wiener Z; Vékey K; Harsányi L; Szűcs Á; Turiák L; Buzás EI
    Biochem Biophys Res Commun; 2018 Apr; 499(1):37-43. PubMed ID: 29550476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of early-stage pancreatic cancer biomarkers.
    Expert Rev Mol Diagn; 2008 Nov; 8(6):675. PubMed ID: 18999919
    [No Abstract]   [Full Text] [Related]  

  • 38. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.
    Nedaeinia R; Manian M; Jazayeri MH; Ranjbar M; Salehi R; Sharifi M; Mohaghegh F; Goli M; Jahednia SH; Avan A; Ghayour-Mobarhan M
    Cancer Gene Ther; 2017 Feb; 24(2):48-56. PubMed ID: 27982021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers.
    Kenner BJ; Go VLW; Chari ST; Goldberg AE; Rothschild LJ
    Pancreas; 2017; 46(10):1238-1241. PubMed ID: 28953187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomes in tumor microenvironment: novel transporters and biomarkers.
    Wang Z; Chen JQ; Liu JL; Tian L
    J Transl Med; 2016 Oct; 14(1):297. PubMed ID: 27756426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.